NorDiag has the following financial calendar for 2012:
 

4th quarter and preliminary annual results 2011
February 16, 2012

Ordinary General Meeting: 
May 8, 2012

1st quarter 2012:
May 24, 2012

2nd quarter and first half year results 2012:
August 29, 2012

3rd quarter 2012:
October 31, 2012

Contact:
CFO Tone Kvåle, Phone: +47 915 19576
 
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 31.6 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.
For further information - www.nordiag.com.

Read the notice in Norwegian here.